Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (R18DK110740)
Received: 15 February 2018
Accepted: 6 April 2018
First Online: 19 April 2018
Ethics approval and consent to participate
: This study protocol has received all necessary ethics approvals from the NYU School of Medicine Institutional Review Board (Reference Number: i16–00690), the VA New York Harbor Healthcare System Office of Research & Development Institutional Review Board (Reference Number MIRB 01609), and the Bellevue Research Review Committee and New York City Health + Hospital’s Research Administration (Reference Number STUDY00000844). Informed consent is collected from participants in accordance with our IRB-approved protocol.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.